PT914166E - Metodos para a esterilidade final de produtos biologicos - Google Patents

Metodos para a esterilidade final de produtos biologicos

Info

Publication number
PT914166E
PT914166E PT97921969T PT97921969T PT914166E PT 914166 E PT914166 E PT 914166E PT 97921969 T PT97921969 T PT 97921969T PT 97921969 T PT97921969 T PT 97921969T PT 914166 E PT914166 E PT 914166E
Authority
PT
Portugal
Prior art keywords
methods
products
compositions obtained
dried sample
methods include
Prior art date
Application number
PT97921969T
Other languages
English (en)
Inventor
Robert Alcock
Jaap Kampinga
Original Assignee
Elan Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Drug Delivery Ltd filed Critical Elan Drug Delivery Ltd
Publication of PT914166E publication Critical patent/PT914166E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT97921969T 1996-05-14 1997-05-14 Metodos para a esterilidade final de produtos biologicos PT914166E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/647,515 US6632648B1 (en) 1996-05-14 1996-05-14 Methods of terminal sterilization of fibrinogen

Publications (1)

Publication Number Publication Date
PT914166E true PT914166E (pt) 2003-12-31

Family

ID=24597275

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97921969T PT914166E (pt) 1996-05-14 1997-05-14 Metodos para a esterilidade final de produtos biologicos

Country Status (14)

Country Link
US (3) US6632648B1 (pt)
EP (1) EP0914166B1 (pt)
JP (1) JP4841018B2 (pt)
AT (1) ATE245455T1 (pt)
AU (1) AU730931B2 (pt)
BR (1) BR9709082A (pt)
CA (1) CA2254914C (pt)
DE (1) DE69723703T2 (pt)
DK (1) DK0914166T3 (pt)
ES (1) ES2202613T3 (pt)
NZ (1) NZ333212A (pt)
PT (1) PT914166E (pt)
WO (1) WO1997042980A1 (pt)
ZA (1) ZA974179B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632648B1 (en) * 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US6383810B2 (en) 1997-02-14 2002-05-07 Invitrogen Corporation Dry powder cells and cell culture reagents and methods of production thereof
US6627426B2 (en) 1997-02-14 2003-09-30 Invitrogen Corporation Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby
EP2172227A3 (en) * 1998-06-30 2011-01-19 Life Technologies Corporation Methods for reducing adventitious agents or toxins in a sample and cell culture reagents produced thereby
BR9905867A (pt) * 1998-11-06 2001-01-23 Bio Sidus S A Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula
DE60035260T2 (de) 1999-02-22 2007-10-18 The University Of Connecticut, Farmington Neue albuminfreie faktor viii formulierungen
JP4493769B2 (ja) * 1999-12-21 2010-06-30 旭化成ケミカルズ株式会社 球形顆粒
EP1372727B1 (en) * 2001-04-04 2010-09-01 DelSiTech Oy Biodegradable carrier and method for preparation thereof
ATE515245T1 (de) 2003-12-11 2011-07-15 Isto Technologies Inc Teilchenförmiges knorpelsystem
WO2005118000A1 (en) 2004-05-27 2005-12-15 Baxter International Inc. Inactivation of a pathogen in a sample by a treatment with formalin and uv light
BRPI0516764B8 (pt) * 2004-10-20 2021-05-25 Ethicon Inc hemostato
PL1913138T3 (pl) 2005-07-29 2017-07-31 Abbott Laboratories Gmbh Sposoby wytwarzania pankreatyny w proszku o niskiej zawartości wirusa
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US8480757B2 (en) 2005-08-26 2013-07-09 Zimmer, Inc. Implants and methods for repair, replacement and treatment of disease
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8182840B2 (en) 2005-09-27 2012-05-22 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
MX2008014763A (es) * 2006-05-22 2008-11-28 Solvay Pharm Gmbh Procedimiento para separar y determinar la carga virica en una muestra de pancreatina.
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
CA2684040C (en) 2007-04-12 2016-12-06 Isto Technologies, Inc. Method of forming an implant using a mold that mimics the shape of the tissue defect site and implant formed therefrom
US20120177610A1 (en) * 2007-09-19 2012-07-12 Kieu Hoang Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
AU2009313325B2 (en) 2008-11-07 2014-05-01 Takeda Pharmaceutical Company Limited Factor VIII formulations
US9827205B2 (en) * 2008-12-12 2017-11-28 Mallinckrodt Pharma Ip Trading D.A.C. Dry powder fibrin sealant
EP2236617A1 (en) 2009-03-31 2010-10-06 Leukocare Ag Methods of terminal sterilization of biofunctional compositions
MX2013000373A (es) * 2010-07-13 2013-02-15 Cephalon Inc Metodos mejorados para la esterilizacion de bendamustina.
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
CA2837878A1 (en) 2011-06-10 2012-12-13 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
WO2013032938A1 (en) 2011-08-26 2013-03-07 Tissuetech, Inc. Methods of sterilizing fetal support tissues
MX354988B (es) 2011-10-25 2018-03-28 Prothena Biosciences Ltd Formulaciones de anticuerpo y metodos.
JP6078838B2 (ja) * 2012-03-31 2017-02-15 学校法人早稲田大学 生体組織の処理方法及び保存用生体組織の製造方法
US10040821B2 (en) 2012-07-11 2018-08-07 Tissuetech, Inc. Compositions containing HC-HA/PTX3 complexes and methods of use thereof
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
TW201642914A (zh) 2015-02-23 2016-12-16 組織科技股份有限公司 用於治療眼部疾病及失調的裝置及方法
HK1250940A1 (zh) 2015-05-20 2019-01-18 Tissuetech, Inc. 用於预防上皮细胞的增殖和上皮-间充质转换的组合物和方法
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
JP2024529107A (ja) 2021-08-13 2024-08-01 ビオテスト・アクチエンゲゼルシャフト フィブリノゲン組成物および調製方法

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557717A (en) 1968-05-17 1971-01-26 Gen Mills Inc Process for making candy floss
US3619294A (en) 1968-07-15 1971-11-09 Penick & Ford Ltd Method of combining crystalline sugar with impregnating agents and products produced thereby
US3632357A (en) 1969-07-29 1972-01-04 Standard Brands Inc Method of producing hard candy
US3655442A (en) 1969-08-27 1972-04-11 California & Hawaiian Sugar Method of making sugar and sugar products
DE2246013A1 (de) 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
US4127502A (en) 1977-06-10 1978-11-28 Eastman Kodak Company Stabilizers for reconstituted, lyophilized samples
LU78955A1 (de) 1978-01-27 1979-09-06 Chimicasa Gmbh Verfahren zur inaktivierung von viren
US4158544A (en) 1978-07-17 1979-06-19 Beckman Instruments, Inc. Process for preparing a biological composition for use as a reference control in diagnostic analysis
US4588744A (en) 1978-09-19 1986-05-13 Mchugh John E Method of forming an aqueous solution of 3-3-Bis(p-hydroxyphenyl)-phthalide
FR2442554A1 (fr) 1978-11-24 1980-06-20 Thomson Brandt Commutateur electronique a commande tactile, et selecteur de canaux comportant un tel commutateur
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4294826A (en) 1980-05-07 1981-10-13 Armour Pharmaceutical Company Process for the preparation of highly purified antihemophilic factor
US4327076A (en) 1980-11-17 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
JPS57140724A (en) 1981-02-25 1982-08-31 Green Cross Corp:The Heat-treatment of aqueous solution containing cold insoluble globulin
US4327077A (en) 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4879280A (en) 1981-09-24 1989-11-07 Fresenius Ag Dialysis solution for use in intraperitoneal dialysis
US4994438A (en) 1981-11-02 1991-02-19 Cedars Sinai Medical Center Heat treatment of lyophilized plasma fractions
US4456590B2 (en) 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
JPS58216695A (ja) 1982-06-07 1983-12-16 Otsuka Shokuhin Kogyo Kk トレハロ−スの製造方法
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
US4883762A (en) 1983-06-06 1989-11-28 Ciba Corning Diagnostics Corp. Stabilized isoenzyme control products
US4865871A (en) 1983-08-23 1989-09-12 Board Of Regents The University Of Texas System Method for cryopreparing biological tissue
US4490361A (en) 1983-12-02 1984-12-25 Alpha Therapeutic Corporation Virus inactivating heat treatment of plasma fractions
AT389815B (de) 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
JPS60258195A (ja) 1984-06-05 1985-12-20 Ss Pharmaceut Co Ltd α．α―トレハロース脂肪酸ジエステル誘導体
DE3434472A1 (de) 1984-09-20 1986-03-27 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur pasteurisation von plasmaproteinen bzw. von plasmaproteinfraktionen
DE3445010A1 (de) 1984-12-10 1986-06-19 Boehringer Mannheim Gmbh Kontroll- bzw. eichserum fuer die lipid-diagnostik
US4677195A (en) 1985-01-11 1987-06-30 Genetics Institute, Inc. Method for the purification of erythropoietin and erythropoietin compositions
GB8505882D0 (en) 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
GB8508173D0 (en) 1985-03-28 1985-05-01 Standard Telephones Cables Ltd Controlled delivery device
US4891319A (en) 1985-07-09 1990-01-02 Quadrant Bioresources Limited Protection of proteins and the like
US4758657A (en) 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
ATE52922T1 (de) 1985-08-05 1990-06-15 Immuno Ag Verfahren zur herstellung von praeparationen auf basis von blutgerinnungsfaktoren.
CA1276563C (en) 1985-09-30 1990-11-20 Stanley E. Charm High temperature, short time heating system and method of sterilizing heat-sensitive biological fluids
JPS62228024A (ja) * 1985-11-30 1987-10-06 Green Cross Corp:The 免疫グロブリンの加熱処理方法
EP0225581A3 (en) * 1985-11-30 1989-05-24 Green Cross Corporation Method for the heat-treatment of immunoglobulins and immunoglobulin product
JPS62174094A (ja) 1985-12-16 1987-07-30 Ss Pharmaceut Co Ltd α．α―トレハロース誘導体
GB8604983D0 (en) 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
JPH0662436B2 (ja) 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US4762857A (en) 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4749783A (en) 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
FR2604157B1 (fr) 1986-09-18 1989-09-01 Air Liquide Structure isotherme
NL8700484A (nl) 1987-02-26 1988-09-16 Victor George Ryhiner Vriesdroogkamer volgens een modulerende directe expansie principe.
US5097018A (en) 1988-05-12 1992-03-17 University Of Southern California Sequential heat treatment of blood-clotting factor products
US5099002A (en) 1987-05-15 1992-03-24 University Of Southern California Sequential improved method for treatment of human blood-clotting factor products
US5118795A (en) * 1987-05-15 1992-06-02 University Of Southern California Sequential heat treatment of blood-clotting factor products
JP2545231B2 (ja) 1987-06-18 1996-10-16 日本ケミカルリサ−チ株式会社 ウロキナ−ゼの加熱による低分子化抑制法
GB8715238D0 (en) 1987-06-29 1987-08-05 Quadrant Bioresources Ltd Food process
US4909940A (en) 1987-12-30 1990-03-20 New York Blood Center, Inc. Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
GB8801338D0 (en) 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
US5045446A (en) 1988-08-26 1991-09-03 Cryopharm Corporation Lyophilization of cells
WO1990011756A1 (en) 1989-04-12 1990-10-18 Aberdeen University Slow release vitreous systems
ES2042138T3 (es) 1989-05-24 1993-12-01 Miles Inc. Filtracion en gel del factor viii tratado termicamente.
GB8917470D0 (en) 1989-07-31 1989-09-13 Quadrant Bioresources Ltd Composition and method
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
IT1246350B (it) 1990-07-11 1994-11-17 Eurand Int Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili
JPH06500632A (ja) 1990-08-10 1994-01-20 アナリティカル・コントロール・システムズ・インコーポレーテッド 改良された診断および治療組成物
US5200399A (en) 1990-09-14 1993-04-06 Boyce Thompson Institute For Plant Research, Inc. Method of protecting biological materials from destructive reactions in the dry state
ES2078052T3 (es) 1991-07-31 1995-12-01 Blatter Farros Ag Aparato rectificador para el rectificado de la superficie cilindrica o esferica de un rodillo en especial de un rodillo de una maquina de manipulacion del papel.
GB9125695D0 (en) 1991-12-03 1992-01-29 Mastavac Limited Medical preparations
DE69212497T2 (de) 1991-12-05 1996-12-12 Mallinckrodt Veterinary, Inc., Mundelein, Ill. Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe
US5192743A (en) 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
IT1254359B (it) * 1992-05-11 1995-09-14 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti il-6
JP3182564B2 (ja) 1992-08-24 2001-07-03 味の素ファルマ株式会社 栄養組成物
US5422384A (en) 1992-11-25 1995-06-06 Battelle Memorial Institute Glass/polymer composites and methods of making
JP3168550B2 (ja) 1992-12-02 2001-05-21 株式会社林原生物化学研究所 脱水剤およびそれを用いる含水物の脱水方法並びにその方法で得られる脱水物品
US5589167A (en) 1993-02-23 1996-12-31 Genentech, Inc. Excipient stabilization of polypeptides treated with organic solvents
WO1995006126A1 (en) 1993-08-24 1995-03-02 Mogen International N.V. Production of trehalose in plants
CN1188171C (zh) 1994-06-02 2005-02-09 廓德伦特控股剑桥有限公司 防止各种特质在再水化或熔化时聚集的方法以及由此获得的组合物
DE69532492T2 (de) 1994-08-31 2004-12-02 Mitsubishi Pharma Corp. Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin
US5512547A (en) 1994-10-13 1996-04-30 Wisconsin Alumni Research Foundation Pharmaceutical composition of botulinum neurotoxin and method of preparation
JPH08157491A (ja) 1994-11-30 1996-06-18 Hayashibara Biochem Lab Inc トレハロース誘導体の製造方法
GB9501040D0 (en) * 1995-01-19 1995-03-08 Quadrant Holdings Cambridge Dried composition
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
DE19528221C2 (de) * 1995-08-01 1998-10-22 Blutspendedienst Der Drk Lande Verfahren zur Herstellung eines virussicheren, therapeutischen Präparates aus Humanplasma
US6632648B1 (en) * 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen

Also Published As

Publication number Publication date
WO1997042980A1 (en) 1997-11-20
US20070249033A1 (en) 2007-10-25
ATE245455T1 (de) 2003-08-15
CA2254914A1 (en) 1997-11-20
NZ333212A (en) 2000-05-26
AU730931B2 (en) 2001-03-22
DE69723703T2 (de) 2004-01-29
EP0914166A1 (en) 1999-05-12
ZA974179B (en) 1997-12-10
EP0914166B1 (en) 2003-07-23
CA2254914C (en) 2008-07-29
JP4841018B2 (ja) 2011-12-21
JP2000511519A (ja) 2000-09-05
DE69723703D1 (de) 2003-08-28
AU2784597A (en) 1997-12-05
BR9709082A (pt) 2001-11-27
ES2202613T3 (es) 2004-04-01
DK0914166T3 (da) 2003-11-10
US20030211592A1 (en) 2003-11-13
US6632648B1 (en) 2003-10-14

Similar Documents

Publication Publication Date Title
PT914166E (pt) Metodos para a esterilidade final de produtos biologicos
CY1105266T1 (el) Αποστειρωση γλυκοκορτικοστepοειδων εναιωρηματων
ES275138U (es) Envase que contiene una pluralidad de pinzas quirurgicas para ligadura esteriles, secas e hidrolizables
FI960281A0 (fi) Menetelmä tuotteiden sterilisoimiseksi
ES2055372T3 (es) Composicion de lavado de las materias queratinicas.
ATE339970T1 (de) Abgabevorrichtung zur abgabe von düften
WO2001037656A3 (en) Preservation of sensitive biological material
ATE357163T1 (de) Warmluftgerät
KR950010898A (ko) 재조합 사람 혈청 알부민 약제학적 제제의 멸균법
DE60010492D1 (de) Verwendung von hydrofluorethern als wärmeübertragungsfluids in niedertemperaturprozessen welche sterilisation benötigen
ATE105194T1 (de) Verfahren zur trocknung und desinfektion von gegenstaenden mittels mikrowellen.
ATE292382T1 (de) Zur inaktivierung von infektiösen proteinen behandelte zusammensetzungen
FI953756A0 (fi) Menetelmä lipidivaipattomien virusten inaktivoimiseksi
ATE253368T1 (de) Verwendung von bisphosphonaten zur prophylaxe und zur behandlung von infektiösen prozessen
AU731581B2 (en) Dry-heat viral inactivation under controlled moisture conditions
DE69733664D1 (de) Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen
CN101757616B (zh) 一种安全的冻干哺乳动物源凝血酶制剂及其制备方法
Qiu et al. Effects of γ‐irradiation, storage and hydration on osteoinductivity of DBM and DBM/AM composite
Rubinstein et al. Inability of solvent-detergent (SD) treated factor VIII concentrate to inactivate parvoviruses and non-lipid enveloped non-A, non-B hepatitis virus in factor VIII concentrate: advantages to using sterilizing 100 degrees C dry heat treatment
ES2149791T3 (es) Procedimiento para la inactivacion de virus en preparaciones de proteinas.
KR20010007907A (ko) 위생 신발장
KR970000100A (ko) 음식물 쓰레기 살균 및 고온 건조 처리장치
JPH0341960A (ja) 電子レンジ用消臭物
RU92003434A (ru) Воздушный стерилизатор
DE3761283D1 (de) Zusammensetzungen zur desinfektion und zur sterilisation.